Patients in pain have major changes to look forward to over the coming months. There are two major companies that supposedly have new products ready for release.

The makers of Oxycontin, Purdue Pharmaceuticals, told me that two new major developments are right around the corner. I would suppose that one would be a better delivery system of the long acting medication making diversion and abuse more difficult. If that is the case, it would ease the availability for the real patients in need of aid. In my humble estimation, easier since division and abuse would be harder.

The other major new development is a new drug for treating pain. This new drug is generically called tapentadol. It will be a short acting medication taken 3 to 4 times a day or every 6 to 8 hours. It is the first entirely new chemical molecule for the treatment of pain since 1984.

I anticipate all these changes to male pain management more exciting than ever before!